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Abstract— Hyperglycemia or high blood glucose (sugar) level 
is a common dangerous complication among patients with Type 
1 diabetes mellitus (T1DM). Hyperglycemia can cause serious 
health problems if left untreated such as heart disease, stroke, 
vision and nerve problems. Based on the electrocardiographic 
(ECG) parameters, we have identified hyperglycemic and 
normoglycemic states in T1DM patients. In this study, a 
classification unit is introduced with the approach of feed 
forward multi-layer neural network to detect the presences of 
hyperglycemic/normoglycemic episodes using ECG parameters 
as inputs. A practical experiment using the real T1DM 
patients’ data sets collected from Department of Health, 
Government of Western Australia is studied. Experimental 
results show that proposed ECG parameters contributed 
significantly to the good performance of hyperglycemia 
detections in term of sensitivity, specificity and geometric mean 
(70.59%, 65.38%, and 67.94%, respectively). From these 
results, it is proved that hyperglycemic events in T1DM can be 
detected non-invasively and effectively by using ECG signals 




It is well recognized that hyperglycemia is detrimental 
and one of the risk factors for adverse outcomes in diabetic 
patients [1]. Persistent hyperglycemia can cause a wide 
range of chronic complications that affect almost every 
system in the body and lead to life-threatening conditions, 
which require immediate medical attention. To detect an 
increase in blood glucose level, a diabetic patient needs to 
frequently monitor blood glucose levels by finger prick 
testing of blood several times a day. This conventional 
method significantly discourages the patients from 
periodically checking blood glucose levels. Therefore, there 
is a strong demand to have a noninvasive technique that 
helps patients to diagnose the disease easily and painlessly.  
New techniques have been employed to develop a minor 
invasive and/or noninvasive method for blood glucose 
monitoring, including infrared spectroscopy [2], 
fluorescence spectroscopy for skin glucose sensing [3], tear 
glucose [4], etc. However, results from these techniques 
need checking frequently against direct blood glucose 
measurements as they cannot replace the direct result of a 
blood glucose sensor [5]. Although real-time continuous 
glucose monitoring systems (CGMS) are now available to 
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give real-time estimations of glucose levels, there still 
remain some limitations including time lag and inaccuracy 
[6]. Due to these limitations, other methods for the detection 
of abnormal blood glucose levels should be studied. 
Among various medical and healthcare information, 
electrocardiography (ECG) is known to be the best way to 
measure and diagnose abnormal rhythms of the heart [7]. 
Several ECG parameters have been investigated to correlate 
with the prevalence of hyperglycemia. Recently, we have 
explored significant abnormal changes of ventricular 
repolarization intervals and certain ECG parameters under 
hyperglycemia and hypoglycemia conditions that could be 
good markers to identify hyperglycemia and hypoglycemia 
in diabetic patients [8]. Reduced heart rate variability has 
been seen among hyperglycemic patients and our previous 
study has demonstrated that high blood glucose levels cause 
significantly lower HRV in subjects with T1DM [9]. Based 
on these explorations, corresponding ECG parameters could 
be determined as good markers for classification models to 
identify hyperglycemic and normoglycemic states in 
diabetics. However, these findings have not yet been 
employed to detect hyperglycemia. There are only a few 
methods to detect hyperglycemia by not using physiological 
signals, such as in exhaled methyl nitrates [10] and early 
detection of ongoing β cell death [11], which are not 
commonly used.  
Artificial neural network (ANN) has been widely applied 
in many scientific areas during the past few years, and is 
currently a very active tool in biomedical research. Most 
applications of ANNs to biomedical are classification 
problems; those are extensively utilized in pattern 
recognition to detect diseases or complex medical 
conditions. Obviously, ANNs can achieve high performance 
and computation rates, which are vital in biomedical 
applications. At least three main studies on hypoglycemia 
detection, which employ ANNs, have achieved excellent 
performances with different computational intelligent 
algorithms [12-14]. Meanwhile, there is no research on 
hyperglycemia detection using ECG so far and no advanced 
computational algorithms have been employed for the 
classification of hyperglycemia. 
In this paper, we propose a new non-invasive 
hyperglycemia detection system, which is based on the 
approach of ANN and electrocardiographic (ECG) signals in 
T1DM patients. Section II provides an overview of the 
method used for non-invasive and continuous detection of 
hyperglycemia. Section III presents the development and 
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results of an optimized neural network to identify 
hyperglycemia using ECG parameters.  A conclusion for this 




In T1DM patients, hyperglycemic state is defined as those 
with more than 1 glucose event  ≥ 150 mg/dl (8.33 mmol/l) 
[15]. A database was compiled on the adolescent patients 
with T1DM who volunteered for overnight hypoglycemia 
and hyperglycemia study from 9pm to 6am at the Princess 
Margaret Hospital for Children in Perth, Australia. To 
prevent the interference of hypoglycemic state that may 
weaken the evaluation of the influence of hyperglycemia in 
changes of cardiac ventricular intervals, this research only 
focuses on subjects with normal and high blood glucose 
levels.  Ten type 1 diabetic patients, who mostly had two 
glycemic states, hyperglycemia (BGL  ≥ 8.33 mmol/l) and 
normoglycemia (3.33 mmol/l < BGL < 8.33 mml/l), are 
chosen for collecting data. All data were collected with 
approval of the Women’s and Children’s Health Service, 
Department of Health, Government of Western Australia, 
and with written informed consent. 
18 data points from each patient were used corresponding 
to the 30-minute duration of each blood glucose sampling 
point. During the study period, ECG signals were 
continuously recorded by a medical device called 
Compumedics with the sampling rate of 512 Hz, while actual 
blood glucose was collected as reference using Yellow 











B. ECG parameters 
30-minute segments of ECG signals were taken according 
to each sampled blood glucose point for collecting ECG 
parameters. Based on the effect of hyperglycemia on ECG 
signals in T1DM, there are sixteen ECG parameters involved 
to detect hyperglycemia. Five ECG intervals including (i) 
HR, (ii) PR, (iii) QTC, (iv) RTC, (v) TPTEC were obtained 
from the patient’s ECG signals using a program written in 
LabVIEW [8]. Index of c in the parameters indicates the 
correction by heart rate for the variables using the Bazett’s 
formula. The other eleven ECG parameters are a selection of 
time domain and frequency domain measures of HRV which 
were considered and performed following the Task Force 
guidelines [16]. 
Time domain measures include: (vi) Mean RR interval 
(MeanRR); (vii) Standard deviation of the RR interval index 
(SDNN); (viii) Root mean square of successive RR interval 
differences (RMSSD); (ix) Percentage of consecutive RR 
intervals that differ by more than 50 ms (pNN50); (x) HRV 
triangular index (HRVi); and (xi) Baseline width of the RR 
interval histogram evaluated through triangular interpolation 
(TINN). Frequency domain measures involve: (xii) Very low 
frequency (VLF); (xiii) Low frequency (LF); (xiv) High 
frequency (HF); (xv) Total spectral power (TotalPw); and 
(xvi) Ratio between LF and HF components (LF/HF). 
HRV analysis was conducted using the Kubios HRV 
analysis software package (http://kubios.uku.fi/). This 
software package was used for analyzing the variability of 
heart beat intervals. It has an easy-to-use graphical interface 
that shows the HRV waveform and calculates the time-
domain, frequency domain, and non-linear dynamics 
parameters from the raw RR signals. The software computed 
all required time and frequency domain features. 
Independent t-test was applied to these features to 
estimate the significant difference between hyperglycemia 
and non-hyperglycemia conditions. Statistical analyses were 
conducted with IBM SPSS version 19 (SPSS Inc, Chicago, 
IL, USA). Significance value (p-value) less than 0.05 is 




In this study, the detection of hyperglycemic state (BGL ≥ 
8.33 mmol/l) using sixteen ECG variables is based on an 
advanced neural network algorithm developed from the 
obtained clinical data. This neural network has a multilayer 
feed-forward neural network structure with one input layer, 
one hidden layer and one output layer. Tansig is the 
hyperbolic tangent sigmoid transfer function used for hidden 
layer and output layer. To accelerate the convergence of the 
error back propagation learning method, the ANN is trained 
by the Levenberg-Marquardt (LM) algorithm.  The output 
layer has one node, which indicates the state of hyper or 
normo. The overall data set consists of a training set, 
validation set, and testing set, which are randomly selected 
with proportions of 35%, 35%, and 30% out of overall data, 
respectively. The validation set is used as an early stopping 
method to make sure the ANN does not over-train. The 
testing set is then used to test the generalization of the neural 
network. For these, the whole data set, which included both 
hyperglycemia data part and non-hyperglycemia data part, 
was used.  
 To measure the performance of the classification results, 
sensitivity and specificity are used [17]. The definitions of 
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where TP (True Positive) is the number of hyperglycemic 
events which are correctly classified as hyperglycemia; FN 
(False Negative) is the number of hyperglycemic events 
which are wrongly classified as normoglycemia; TN (True 
Negative) is the number of normoglycemic events which are 
correctly classified as normoglycemia; FP (False Positive) is 
the number of normoglycemic events which are wrongly 
classified as hyperglycemia. 
 For the comparison of the performances, a geometric 
mean gm was also used. The geometric mean equals to the 
square root of the multiplication of sensitivity and 
specificity. The geometric mean is suitable to indicate 
performance of a detection system with imbalanced data 
[18]. In our study, the number of normoglycemia data is 
about double the number of hyperglycemia data. Moreover, 
four other training methods were also applied to the neural 
network model to compare their performances with the 
proposed one. They are Gradient descent, Gradient descent 
with momentum, Scaled conjugate gradient, Resilient back 
propagation, which are called LM, GD, GDX, SCG and RP, 
respectively. The same condition was kept in initializing all 
the networks. Same input, training parameters and learning 
function were adopted during training process for those five 
learning algorithms. 
 
III. RESULTS AND DISCUSSION 
Normalization was used to reduce patient-to-patient 
variability and to enable group comparison by subtracting the 
patient’s ECG features to his/her min values and then 
dividing the results by the differences between the maximum 
and minimum values [19]. The normalized data will be set in 
the range between 0 and 1. 
The responses from 10 T1DM patients, as shown in Table 
I, exhibited significant changes during the hyperglycemic 
state against normoglycemic state. It can be seen that 
thirteen out of sixteen parameters in hyperglycemia 
significantly differed from those in normoglycemia, 
indicating that a rise in blood glucose levels is associated 
with a drop in QTC, RTC, TpTeC and HRV measures. 
The neural networks applying five algorithms, namely 
LM, SCG, GDX, CGF, and RP used all 16 original ECG 
parameters as inputs. The number of hidden neurons varied 
between 3 and 20 neurons until the best classification was 
reached with the minimum mean square error (MSE). Table 
I shows the best results in terms of sensitivity, specificity 
and geometric mean from testing set with different input and 
best numbers of hidden nodes. 
LM algorithm, 9 hidden nodes produce the best 
classification in which the training results of 89.47% 
sensitivity and 83.87% specificity are gained and the testing 
set leads to 70.59% sensitivity and 65.38% specificity. These 
testing sensitivity and specificity are considered to be a 
satisfactory result which meets the requirements of disease 
diagnosis (sensitivity ≥ 70% and specificity ≥ 50%). The best 
testing geometric mean of 67.94% by using LM algorithm is 
also achieved with these sensitivity and specificity. Apart 
from LM, the sensitivities of the other four algorithms are 
less than 70%, which are not directed in biomedical 
application. 
TABLE I.  CHANGES OF NORMALIZED 16 ECG PARAMETERS UNDER 
HYPERGLYCEMIA CONDITIONS COMPARED TO NORMOGLYCEMIC 
CONDITIONS 
Parameters Hyperglycemia Normoglycemia p value 
HR 0.313 ± 0.160 0.342 ± 0.187 0.346 
QTC 0.438 ± 0.204 0.536 ± 0.181 0.003 
PR 0.572 ± 0.229 0.429 ± 0.229 < 0.0001 
RTC 0.433 ± 0.231 0.552 ± 0.190 0.001 
TpTeC 0.27 ± 0.167 0.337 ± 0.185 0.03 
VLF 0.016 ± 0.018 0.06 ± 0.129 0.001 
LF 0.016 ± 0.022 0.047 ± 0.108 0.006 
HF 0.077 ± 0.101 0.151 ± 0.193 0.002 
Total Pw 0.032 ± 0.035 0.080 ± 0.120 < 0.0001 
LF/HF 0.092 ± 0.103 0.111 ± 0.167 0.455 
MeanRR 0.475 ± 0.245 0.543 ± 0.2 0.077 
SDNN 0.128 ± 0.085 0.203 ± 0.146 < 0.0001 
RMSSD 0.220 ± 0.131 0.303 ± 0.167 0.002 
pNN50 0.368 ± 0.211 0.462 ± 0.189 0.005 
HRVi 0.469 ± 0.167 0.552 ± 0.176 0.005 
TINN 0.393 ± 0.176 0.506 ± 0.197 < 0.0001 
 
TABLE II.  BEST PERFORMANCES OF HYPERGLYCEMIA DETECTION 
USING DIFFERENT LEARNING ALGORITHMS 
 
Hyperglycemia detection has been performed with other 
methods to compare with the performance of the proposed 
ANN model. Linear Discriminant Analysis (LDA) and K-
Nearest Neighbors (KNN), two of the most conventional and 
common classification techniques, have been chosen for the 
comparison. The methods are applied to the same ECG 
dataset from 10 diabetic patients. LDA and KNN classifiers 
have been run in training, validation and testing sets with 
proportions of 35%, 35%, and 30% out of overall data, 
respectively. The performances have been undertaken by 
using the Classification Toolbox (version 3.1) in Matlab.  
Different numbers of folds for cross-validation have been 
























LM 9 89.47 83.87 86.63 80 77.41 78.69 70.59 65.38 67.94 
GDX 12 78.57 81.82 80.18 75 61.76 68.06 66.67 54.84 60.47 
SCG 10 72.22 68.75 70.46 90.91 53.57 69.79 68.75 59.26 63.83 
RP 11 88.89 68.75 78.17 72.73 75 73.86 62.5 62.96 62.73 
CGF 7 82.35 81.82 82.09 71.42 86.21 78.47 55.56 68 61.47 
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detection. Finally, LDA used 3-fold and KNN used 4-fold 
cross validation with venetian blinds which achieved the best 
outcomes, as shown in Table III. Compared to the 
performance of ANN model using Levenberg-Marquardt for 
hyperglycemia detection, LDA and KNN still got worse 
results with lower sensitivities and their sensitivities were 
much less than their specificities in all three sets of training, 
validation and testing. The best testing sensibilities of LDA 
and KNN are 50% and 43.75%, which are poorer than the 
sensibility of ANN (70.59%).  Even Specificities of LDA 
and KNN are higher than ANN’s (77.78% and 85.19% vs. 
65.38%), LDA and KNN do not satisfy with the 
requirements for disease diagnosis. In general, ANN 
outperforms LDA and KNN with higher achievement in 
overall accuracy. 
TABLE III.  COMPARISON OF BEST PERFORMANCES OF THREE 
DIFFERENT CLASSIFICATION TECHNIQUES FOR HYPERGLYCEMIA 
DETECTION 
 
For future research, we are continuing to develop 
advanced algorithms and optimization techniques to improve 
overall accuracy of hyperglycemia detection. The results of 
this study might require further validation using different 
ECG feature extraction methods to yield higher 
performance. Moreover, a strategy of reducing dimension of 
input size should be carried out to set up a set of interrelated 
parameters and find important ECG parameters, which 
significantly contribute to the performance of hyperglycemia 
detection. This hyperglycemia detection strategy, after 
further validation, could be a useful non-invasive and 
painless method for diabetic patients. 
 
IV. CONCLUSION 
In this paper, a classification unit using artificial neural 
network is developed to determine the presence of 
hyperglycemia episodes based on T1DM patients’ ECG 
parameters. The results of 70.59% sensitivity and 65.58% 
specificity by using LM algorithm are considered reasonable 
and meet the requirement for biomedical application. 
Various training algorithms also have been developed and 
compared. In general, the proposed ECG classifier using LM 
algorithm outperforms other algorithms. This result indicates 
that hyperglycemic events in T1DM can be detected non-
invasively and effectively by using ECG signals and ANN 
approach. 
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